Academic Institute

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 79%
3. Genes 65%
4. Transplants 53%
5. Kidney 46%
6. Proteins 46%
7. Breast Neoplasms 44%
8. T-Lymphocytes 43%
9. Lung 43%
10. Mortality 37%
11. Brain 36%
12. Wounds and Injuries 36%
13. Survival 34%
14. Blood Vessels 34%
15. Eye 34%
16. Coronary Vessels 33%
17. DNA 32%
18. Heart Failure 32%
19. Population 30%
20. Growth 29%
21. Stroke 29%
22. Atherosclerosis 28%
23. Calcium 28%
24. Post-Traumatic Stress Disorders 28%
25. Coronary Artery Disease 28%
26. In Vitro Techniques 28%
27. Magnetic Resonance Imaging 28%
28. Pharmaceutical Preparations 27%
29. Heart 27%
30. Polychlorinated Dibenzodioxins 27%
31. Infections 26%
32. Liver 26%
33. Mutation 26%
34. Equipment and Supplies 26%
35. Prostatic Neoplasms 25%
36. Safety 25%
37. Carcinoma 25%
38. Allografts 25%
39. Cardiovascular Diseases 25%
40. Neoplasm Metastasis 24%
41. Myocardial Infarction 24%
42. Apoptosis 24%
43. Gene Expression 23%
44. Drug Therapy 23%
45. Biopsy 23%
46. Incidence 22%
47. Radiotherapy 22%
48. Tomography 22%
49. Messenger RNA 22%
50. Surgeons 22%
51. Aryl Hydrocarbon Receptors 21%
52. Placebos 21%
53. Recurrence 21%
54. Systematic Reviews 21%
55. Skin 20%
56. Parkinson Disease 20%
57. Inflammation 20%
58. Guidelines 20%
59. Macrophages 20%
60. Tissue Donors 20%
61. Phenotype 20%
62. Liver Transplantation 19%
63. Antibodies 19%
64. Veterans 19%
65. Prostate 19%
66. Confidence Intervals 19%
67. Stents 19%
68. Serum 19%
69. Ligands 19%
70. Registries 18%
71. Magnetic Resonance Spectroscopy 18%
72. Pathology 18%
73. Stem Cells 18%
74. Cell Line 18%
75. Technology 18%
76. Estrogen Receptors 18%
77. Heart-Assist Devices 18%
78. Transcatheter Aortic Valve Replacement 18%
79. Clinical Trials 18%
80. Biomarkers 18%
81. Health 18%
82. Transplant Recipients 18%
83. Adenocarcinoma 18%
84. Child 17%
85. Streptococcus 17%
86. Endothelial Cells 17%
87. Injections 17%
88. Exercise 17%
89. Urinary Bladder 17%
90. Pediatrics 17%
91. Transplantation 17%
92. Randomized Controlled Trials 17%
93. Breast 17%
94. Lung Neoplasms 17%
95. Amyotrophic Lateral Sclerosis 17%
96. Costs and Cost Analysis 17%
97. Enzymes 17%
98. Lipids 17%
99. Animals 17%
100. Cytokines 17%